TABLE 3.
Efficacy of immunizations evaluated at 7 days after the sixth immunization obtained with protocols B, D, I, and L
Ag | Protocol | Mean titera |
Downregulation |
||
---|---|---|---|---|---|
IgA | IgG | Ex vivob | In vitroc | ||
FHV-ECL1 | B | 20 | 100 | 39 | ND |
D | 60 | 300 | 32.5 | ND | |
I | 60 | 900 | 53 | 69 | |
L | 250 | 1,300 | 69.6 | 75 | |
FHV-ECL2 | B | 20 | 100 | 33.3 | ND |
D | 66 | 300 | 49 | ND | |
I | 10 | 433 | 67 | 53 | |
L | 300 | 1,235 | 67 | 62 | |
FHV-Nter1 | B | 0 | 30 | 22 | ND |
D | 0 | 200 | 25.7 | ND | |
I | 30 | 1,500 | 39 | 37 | |
L | 100 | 750 | 43 | 43 | |
FHV-Nter2 | B | 0 | 0 | 0 | ND |
D | 0 | 200 | 0 | ND | |
I | 0 | 50 | 0 | ND | |
L | 0 | 150 | 0 | ND | |
FHV (CTRL) | B | 0 | 0 | 0 | ND |
D | 0 | 0 | 0 | ND | |
I | 0 | 0 | 0 | ND | |
L | 0 | 0 | 0 | ND |
The values are mean titers of binding antibodies to the different CCR5 domains, expressed as a serum dilution of 1/n (where n is the number shown).
Ex vivo CCR5 downregulation is expressed as percent reduction of CCR5 molecules on the surfaces of murine PBMC from immunized animals.
In vitro CCR5 downregulation was induced in the U937 cell line by murine antisera, and it is expressed as percent receptor internalization obtained at a serum dilution of 1/40. ND, not detectable.